Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3597-44-2

17-alpha-hydroxy-3,11-dioxoandrost-4-ene-17-beta-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

3597-44-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • Androst-4-ene-17-carboxylicacid, 17-hydroxy-3,11-dioxo-, (17a)- (9CI)

    Cas No: 3597-44-2

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 3597-44-2 Structure

  • Basic information

    1. Product Name: 17-alpha-hydroxy-3,11-dioxoandrost-4-ene-17-beta-carboxylic acid
    2. Synonyms: 17-hydroxy-3,11-dioxoandrost-4-ene-17-carboxylic acid
    3. CAS NO:3597-44-2
    4. Molecular Formula: C20H26O5
    5. Molecular Weight: 346.4174
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 3597-44-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 567.7°C at 760 mmHg
    3. Flash Point: 311.2°C
    4. Appearance: N/A
    5. Density: 1.31g/cm3
    6. Vapor Pressure: 2.99E-15mmHg at 25°C
    7. Refractive Index: 1.593
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 17-alpha-hydroxy-3,11-dioxoandrost-4-ene-17-beta-carboxylic acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: 17-alpha-hydroxy-3,11-dioxoandrost-4-ene-17-beta-carboxylic acid(3597-44-2)
    12. EPA Substance Registry System: 17-alpha-hydroxy-3,11-dioxoandrost-4-ene-17-beta-carboxylic acid(3597-44-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 3597-44-2(Hazardous Substances Data)

3597-44-2 Usage

Type

Synthetic androgen and anabolic steroid

Parent compound

Testosterone

Potency

Potent androgenic hormone

Medical use

Promotes muscle growth and masculine characteristics in men with low testosterone levels

Agricultural use

Promotes growth and improves feed efficiency in livestock

Legal status

Controlled substance in many countries

Potential for abuse

High due to its anabolic and androgenic effects

Negative side effects

Liver toxicity and cardiovascular risks

Application

Medical treatment and agricultural use

Chemical structure

Modified testosterone molecule with a methyl group at the 17-alpha position and a carboxylic acid group at the 17-beta position

Mechanism of action

Binds to androgen receptors, promoting the development of male characteristics and increasing protein synthesis in muscle cells

Check Digit Verification of cas no

The CAS Registry Mumber 3597-44-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,9 and 7 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 3597-44:
(6*3)+(5*5)+(4*9)+(3*7)+(2*4)+(1*4)=112
112 % 10 = 2
So 3597-44-2 is a valid CAS Registry Number.

3597-44-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-17-carboxylic acid

1.2 Other means of identification

Product number -
Other names 17-hydroxy-3,11-dioxo-21-nor-pregnen-(4)-oic acid-(20)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3597-44-2 SDS

3597-44-2Relevant articles and documents

Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids

-

, (2008/06/13)

Methods for treating angiogenesis, tumors, and ocular hypertension with steroids are disclosed herein. The steroids have angiostatic activity with reduced glucocorticoid activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3597-44-2